Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Keyword(s):
Phase 2
◽
2008 ◽
Vol 58
(2)
◽
pp. AB128
2011 ◽
Vol 64
(2)
◽
pp. AB160
Keyword(s):
2011 ◽
Vol 64
(2)
◽
pp. AB156
Keyword(s):